NL-OMON33907CompletedPhase 4
Clinical Evaluation Of Vanguard Deep Dish Rotating Platform Knee Prosthesis - Vanguard Deep Dish
Biomet Nederland BV0 sites100 target enrollmentStarted: TBDLast updated:
Trial Snapshot
- Phase
- Phase 4
- Status
- Completed
- Sponsor
- Enrollment
- 100
Study Overview
Brief Summary
No summary available.
Study Design
- Study Type
- Interventional
Eligibility Criteria
- Ages
- 18 to 99 (—)
Inclusion Criteria
- •Patients with a pre-operative knee score of < 70.
- •Patients scheduled to undergo primary total knee replacement because of a painful and disabled knee joint resulting from osteoarthritis.
- •Ability and willingness to follow instructions and to return for follow-up evaluations.
- •Patients who are at least 18 years of age.
- •Consent form read, understood, and signed by patient.
Exclusion Criteria
- •Osteomyelitis.
- •Previous partial or total prosthetic knee replacement on the operative side.
- •Patients who had body mass index >40
Investigators
Similar Trials
Active, not recruiting
Not Applicable
Clinical Evaluation of Vanguard DD RPKnee OsteoarthritisPost-traumatic OsteoarthritisRheumatoid ArthritisNCT04076202Zimmer Biomet113
Completed
Not Applicable
Vanguard™ Deep Dish Rotating Platform Knee Clinical EvaluationOsteoarthritisNCT00753090Zimmer Biomet326
Active, not recruiting
Not Applicable
Quality of life and patient satisfaction in patients on automated peritoneal dialysis with remote peritoneal dialysis monitoring system: a prospective, randomized controlled, multicenter studyKCT0003390Kyungpook National University Hospital60
Completed
Not Applicable
A study on the clinical application of a new device utilizing antiboy-DEPIM method for the detection of periodontopathic bacteriaPeriodontal diseaseJPRN-UMIN000012181Tokyo Dental College40
Completed
Not Applicable
Treatment outcomes of reduced-dose ganciclovir injectioCMVR lesionvisual acuityintraocular pressurecytomegalovirus retinitisganciclovirintravitreal injectionstreatment outcomesTCTR20160316001Siriraj Development Research Fund (managed by Routine to Research:R2R)60